leadf
logo-loader
viewJPMorgan Chase & Co

JP Morgan shares lifted as Q4 profit beats expectations

US banking titan JP Morgan Chase kicked off earnings season with aplomb and shares nudged higher in pre-market as it posted analyst-beating fourth quarter profits..

JP Morgan shares lifted as Q4 profit beats expectations
JP Morgan Q4 profits beat expectations....

US banking titan JP Morgan Chase (NYSE:JPM) kicked off earnings season with aplomb and shares nudged higher in pre-market as it posted analyst-beating fourth quarter profits..

For the three months to December 31,2015, net profit was US$5.43 billion, or US$1.32 per share, compared to US $4.93bn for the same quarter of 2014.

Analysts had expected earnings of $1.25 a share.

Revenues in the quarter rose to US$23.75 billion against analyst expectations of US$22.89 billion.

Notably, profits in the group's investment banking business increased considerably to US$1.75 billion from US$972 million in the fourth quarter of 2014.

Chief executive Jamie Dimon told investors: " "We had a good quarter as 2015 came to a close. The businesses generated strong loan growth and credit quality, except for some stress in energy.

"The consumer business continues to gather deposits, outpacing the industry. Markets were somewhat quieter, and we saw the impact reflected in the results of our trading and Asset Management businesses.”

Dimon added: "We see exciting opportunities to invest for the future, to continue to deliver better and faster for our clients and customers.”

Ahead of the bell in New York, shares are up 1.78% to US$58.36 each.

Quick facts: JPMorgan Chase & Co

Price: 102.88 USD

NYSE:JPM
Market: NYSE
Market Cap: $313.6 billion
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

4D pharma plc merges with SPAC company Longevity Acquisition Corp

4D pharma plc (LON:DDDD) CEO Duncan Peyton tells Proactive the group is to get a cash injection of US$14.6mln through a merger with Longevity Acquisition Corporation (NASDAQ:LOAC), a special purpose acquisition company. Peyton says the merger will accelerate and de-risk 4D's admission to...

1 hour, 11 minutes ago

2 min read